Cargando…

Is Polymicrobial Bacteremia an Independent Risk Factor for Mortality in Acinetobacter baumannii Bacteremia?

This retrospective observational study assessed the differences between monomicrobial and polymicrobial A. baumannii bacteremia and identified possible independent risk factors for 14-day mortality. There were 379 patients with A. baumannii bacteremia admitted to a tertiary care center in northern T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yung-Chih, Ku, Wen-Wei, Yang, Ya-Sung, Kao, Chih-Chun, Kang, Fang-Yu, Kuo, Shu-Chen, Chiu, Chun-Hsiang, Chen, Te-Li, Wang, Fu-Der, Lee, Yi-Tzu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019703/ https://www.ncbi.nlm.nih.gov/pubmed/31935954 http://dx.doi.org/10.3390/jcm9010153

Ejemplares similares

Biofilm formation is not an independent risk factor for mortality in patients with Acinetobacter baumannii bacteremia
por: Chiang, Tsung-Ta, et al.
Publicado: (2022)

Carbapenem Breakpoints for Acinetobacter baumannii Group: Supporting Clinical Outcome Data from Patients with Bacteremia
por: Lee, Yi-Tzu, et al.
Publicado: (2016)

Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis
por: Yang, Ya-Sung, et al.
Publicado: (2013)

Evolution of Acinetobacter baumannii in Clinical Bacteremia Patients
por: Li, Henan, et al.
Publicado: (2021)

Risk Factors for Mortality in Patients with Acinetobacter baumannii Bacteremia
por: Park, Se Yoon, et al.
Publicado: (2013)

Polymicrobial community-acquired Acinetobacter baumannii and Burkholderia pseudomallei bacteremia: opportunistic infections with similar risk factors in northern Australia
por: Fairhead, Lee, et al.
Publicado: (2020)

Initial indicators for the prognosis of Acinetobacter Baumannii bacteremia in children
por: Hong, Yi, et al.
Publicado: (2023)

Bacterial membrane vesicles from Acinetobacter baumannii induced by ceftazidime are more virulent than those induced by imipenem
por: Chiu, Chun-Hsiang, et al.
Publicado: (2020)

Evaluation of outcome in critically ill patients with Acinetobacter baumannii bacteremia
por: Pratikaki, M, et al.
Publicado: (2005)

Risk Factors and Clinical Outcomes for Patients With Acinetobacter baumannii Bacteremia
por: Gu, Zhenyang, et al.
Publicado: (2016)

Risk Factors, Clinical Presentation, and Outcome of Acinetobacter baumannii Bacteremia
por: Ballouz, Tala, et al.
Publicado: (2017)

Polymicrobial Bacteremia Involving Comamonas testosteroni
por: Orsini, Jose, et al.
Publicado: (2014)

A case of disseminated intravascular coagulation secondary to Acinetobacter lwoffii and Acinetobacter baumannii bacteremia
por: Baldeo, Candice, et al.
Publicado: (2015)

Acinetobacter baumannii bacteremia, a rare complication of endoscopic retrograde cholagiopancreatography!
por: Jabri, Hadoun, et al.
Publicado: (2014)

Bacteremia by colistin-resistant Acinetobacter baumannii isolate: a case report
por: Garcia Casallas, Julio Cesar, et al.
Publicado: (2019)

1855. Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia
por: Lee, Chan Mi, et al.
Publicado: (2022)

249. A metabolomic study of patients with A. baumannii bacteremia
por: Sun, Hsin-Yun, et al.
Publicado: (2020)

Confronting Tigecycline-Resistant Acinetobacter baumannii via Immunization Against Conserved Resistance Determinants
por: Chiang, Ming-Hsien, et al.
Publicado: (2020)

Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients With Carbapenem-Resistant Acinetobacter baumannii Bacteremia
por: Son, Hyo-Ju, et al.
Publicado: (2020)

Biofilm formation is not associated with worse outcome in Acinetobacter baumannii bacteraemic pneumonia
por: Wang, Yung-Chih, et al.
Publicado: (2018)

Colistin-Resistant Acinetobacter Baumannii Bacteremia: A Serious Threat for Critically Ill Patients
por: Papathanakos, Georgios, et al.
Publicado: (2020)

1824. Combination therapy of daptomycin/colistin for extreme drug resistant Acinetobacter baumannii bacteremia
por: Lampada, Charis, et al.
Publicado: (2022)

Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia: Impact of Appropriate Antimicrobial Therapy
por: Kim, Youn Jeong, et al.
Publicado: (2012)

135. Clinical and Microbiologic Analysis of Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia
por: Cho, Eunbeen, et al.
Publicado: (2019)

Acinetobacter radioresistens infection with bacteremia and pneumonia
por: Wang, Tina, et al.
Publicado: (2019)

Influence of severity of infection on the effect of appropriate antimicrobial therapy for Acinetobacter baumannii bacteremic pneumonia
por: Kang, Fang-Yu, et al.
Publicado: (2020)

Polymicrobial bacteremia after treatment of transcatheter arterial chemoembolization: A case report
por: Fang, Xue-Yao, et al.
Publicado: (2019)

A Case of Polymicrobial Bacteremia in a Patient Undergoing Chemotherapy
por: Arahata, Kyoko, et al.
Publicado: (2018)

Polymicrobial bacteremia and Strongyloides hyperinfection syndrome: Vigilance in patients on corticosteroids
por: Boyle, Evan, et al.
Publicado: (2022)

A Population-Based Evaluation of Polymicrobial Staphylococcus aureus Bacteremia
por: Hindy, Joya-Rita, et al.
Publicado: (2022)

331. Blood Culture Identification (BCID) Performance in Polymicrobial Bacteremia
por: Bradford, William, et al.
Publicado: (2022)

Prevalence of Acinetobacter baumannii bacteremia in intensive care units of Ibn Rochd University Hospital, Casablanca
por: El Kettani, Assiya, et al.
Publicado: (2017)

Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
por: Park, So Yeon, et al.
Publicado: (2019)

High and Increasing Oxa-51 DNA Load Predict Mortality in Acinetobacter baumannii Bacteremia: Implication for Pathogenesis and Evaluation of Therapy
por: Chuang, Yu-Chung, et al.
Publicado: (2010)

Risk Factors for Occurrence and 30-Day Mortality for Carbapenem-Resistant Acinetobacter baumannii Bacteremia in an Intensive Care Unit
por: Kim, Song Yee, et al.
Publicado: (2012)

Risk Factors for and Clinical Outcomes of Polymicrobial Acinetobacter baumannii Bloodstream Infections
por: Qian, Zhenhua, et al.
Publicado: (2022)

Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit
por: Jung, Ji Ye, et al.
Publicado: (2010)

Subsequent Multidrug-Resistant Bacteremia Is a Risk Factor for Short-Term Mortality of Patients with Ventilator-Associated Pneumonia Caused by Acinetobacter baumannii in Intensive Care Unit: A Multicenter Experience
por: Ju, Mo-Han, et al.
Publicado: (2018)

Determinants of Mortality in Patients with Nosocomial Acinetobacter baumannii Bacteremia in Southwest China: A Five-Year Case-Control Study
por: Yang, Shuangshuang, et al.
Publicado: (2018)

A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii
por: Chiu, Chun-Hsiang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hoj923i4aoa9d2sj0bt1r7a5vu